Material and methods: A retrospective gastric cancer chemotherapy was carried out on series of patients admitted in the period June - March The duration of hospitalization was between 1 and 61 days, with an average of The data from observation files, the operating protocols, pathology reports and follow-up files were collected and analyzed.
The most common complication was septic shock and mortality was 9. Average survival was 5.
- Pictures of nasal papillomas
- The influence of isorel on the advanced colorectal cancer. - 中国知网
Conclusion: PC-GI is a disease with a poor prognosis, posing difficulties in early diagnosis, establishing the surgical indication and protocol. Consistent advances in systemic and locoregional chemotherapy, surgical techniques, intraoperative radiotherapy, as well as immunotherapy are expected to improve prognosis.
Author Biographies I. Evidence-based medicine in the treatment of peritoneal carcinomatosis: Past, present, and future.
J Surg Oncol ; Prognostic significance of tumor markers in peritoneal lavage in advanced gastric cancer. Oncology ; Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement.
Debate: Does radiation therapy play a role in gastric cancer adjuvant therapy? - Yes
Nucl Med Commun ; Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol ; Gastric cancer chemotherapy morbidity gastric cancer chemotherapy mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy.
Blog aimed at residents in surgery URL : www. Romeo Giuli MD, resident. School of General and Emergency Surgery.
Ann Surg Oncol ; Cost of an intraperitoneal chemohyperthermia IPCH related to cytoreductive surgery. Ann Chir ; Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy HIPEC. Eur J Surg Oncol ; Onkologie ; Morbidity and mortality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis.
Combined surgery, chemotherapy, and radiotherapy improved survival, but the side effects and the poor performance status of the patients seriously affect the use of these methods. Isorel is aqueous extract well known for its gastric cancer chemotherapy effects obtained by various in vitro and in vivo experimental models and which was validated by an in vitro bioassay on murine melanoma B16F10 and human gastric cancer chemotherapy carcinoma HeLa cells. Hence, it was further used in a prospective, randomized, and controlled study which compared the postoperative results for patients with colorectal cancer stages Dukes C 40 patients and D 24 patients who, beside surgery, received either only chemotherapy 5-FU6 cycles either the Mayo or the De Gramont protocol or chemotherapy combined with Isorel biotherapy. We noted no toxic deaths due to either chemo or biotherapy.
J BUON ; Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and gastric cancer chemotherapy intraperitoneal chemotherapy still be regarded as a highly morbid procedure? Ann Surg ; Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy IHPC : postoperative morbidity and mortality and short-term follow-up.
Ann Ital Chir ;